Compounding pharmacies in South Carolina
By the PeptideAgent Editorial Team. Draft, pending editorial review. Last verified
The South Carolina Board of Pharmacy (South Carolina Department of Labor, Licensing and Regulation) regulates compounding pharmacies in South Carolina. Compounded GLP-1 limited. How to check a pharmacy's license, plus verified listings.
South Carolina at a glance
- Pharmacy regulator
- South Carolina Board of Pharmacy (South Carolina Department of Labor, Licensing and Regulation)
- 503A framework
- Follows the federal 503A framework
- Telehealth prescribing
- Regulatory: Telehealth allowed
- Asynchronous prescribing
- Regulatory: Async unclear
- Compounded GLP-1 access
- Regulatory: Compounded GLP-1 limited
Verified compounding pharmacies serving South Carolina
No verified compounding pharmacies serving South Carolina are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.
Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.
Run a pharmacy, clinic, or telehealth service? Apply for a listing.
Who regulates compounding pharmacies in South Carolina
The Board of Pharmacy regulates pharmacies under the South Carolina Pharmacy Practice Act (title 40, chapter 43). Section 40-43-83 requires a permit for in-state facilities and for each permittee outside South Carolina that ships, mails, or delivers prescription drugs into the state, and allows the Board to refuse a permit that is not in the public interest. Section 40-43-86 sets facility and practice requirements, including compounding; subsection (CC)(2) bars pharmacists from offering compounded medications to other pharmacies for resale. The Board's non-resident pharmacy permit application states that South Carolina has no separate sterile or non-sterile compounding permit, but any applicant that compounds must submit its compounding documentation even if it does not plan to ship compounds into the state: for non-sterile work, 6 hours of initial and 4 hours of annual compounding education for pharmacists and technicians, a diagram and photographs of the compounding area, and temperature, humidity, and cleaning logs; for sterile work, compounding training records, a diagram and photographs of the sterile area, a month of pressure differential, temperature, humidity, and cleaning logs, and the last certification of hoods and clean areas. The Board's permit page adds that under Regulation 99-43(G)(3)(b) the pharmacist-in-charge or permit holder must appear before the Non-Resident Application Review Committee in lieu of an in-person inspection. South Carolina has not adopted a separate state list of compoundable bulk substances, so eligibility follows the federal 503A test (approved drug component, USP or NF monograph, or FDA 503A bulks list). [1] [3] [4] [5] [6] [7] [8]
Compounded GLP-1 access in South Carolina
Telehealth GLP-1 patients should confirm that the prescriber holds a South Carolina license and that any mail order pharmacy holds a South Carolina nonresident permit under section 40-43-83. [2] [4] [10]
Research use only sellers in South Carolina
The South Carolina Pharmacy Practice Act limits dispensing of prescription drugs to permitted pharmacies and licensed practitioners, so an online seller shipping "research use only" injectable peptides to South Carolina consumers is not operating as a pharmacy under chapter 43. The South Carolina Board of Medical Examiners has also issued a notice that a physician may not compound, administer, prescribe, or dispense research-grade or FDA-ineligible peptides, may not delegate those acts to APRNs or PAs, and cannot rely on a patient consent form. The notice states that facilities inside or outside South Carolina may not sell or dispense drugs without a Board of Pharmacy license (S.C. Code 40-43-83 and 40-43-89), that physicians, APRNs, PAs, and pharmacists must buy all prescription products and compounding ingredients from Board of Pharmacy permitted entities, and that buying from an unpermitted source can be misconduct under S.C. Code 40-47-110(B). [3] [11] [12]
How to check a compounding pharmacy in South Carolina
- Search the South Carolina Board of Pharmacy (South Carolina Department of Labor, Licensing and Regulation) license lookup for the pharmacy by name. A pharmacy based elsewhere needs whatever license or registration South Carolina requires before it ships to you. [1] [3] [4] [5] [6] [7] [8]
- Ask whether it operates as a 503A pharmacy or a 503B outsourcing facility, and confirm a 503B claim against FDA's outsourcing facility information (see the verification checklist).
- Confirm the peptide can be lawfully compounded: check its status on the regulatory tracker or its peptide page before paying.
- Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in South Carolina. [3] [11] [12]
Common questions in South Carolina
Does an out-of-state pharmacy need a South Carolina permit to mail me compounded peptides?
Yes. Section 40-43-83 requires out-of-state pharmacies that ship or deliver prescription drugs to South Carolina residents to hold a Board of Pharmacy permit, and the Board can refuse a permit it finds is not in the public interest. The Board's non-resident application requires any pharmacy that compounds to document compounding training, submit a diagram and photographs of its compounding areas, and provide environmental and cleaning logs, and its pharmacist-in-charge or permit holder must appear before the Board's Non-Resident Application Review Committee. [1] [4] [6] [7]
Can a South Carolina pharmacy compound peptides that are not on the FDA bulks list?
Generally no. South Carolina has no state bulks list of its own, so the federal 503A test applies: the substance must be a component of an approved drug, have a USP or NF monograph, or be on the FDA 503A bulks list. Peptides in FDA Category 2 cannot be compounded. [5] [8] [9]
Sources
- [1]South Carolina Board of Pharmacy (Department of Labor, Licensing and Regulation)
- [2]South Carolina Code section 40-47-37, Practice of telemedicine, requirements (title 40, chapter 47)
- [3]South Carolina Code title 40, chapter 43, South Carolina Pharmacy Practice Act
- [4]South Carolina Code section 40-43-83, In-state facilities and out-of-state mail order pharmacy service permits
- [5]South Carolina Code section 40-43-86, Facility requirements for pharmacies, including compounding
- [6]South Carolina Board of Pharmacy: Non-Resident Pharmacy Permit Application, including non-sterile and sterile compounding requirements (revised February 2019)
- [7]South Carolina Board of Pharmacy: facility permit types and non-resident application review
- [8]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
- [9]FDA: Certain bulk drug substances for use in compounding may present significant safety risks (503A and 503B category lists)FDA
- [10]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
- [11]21 U.S.C. 331, Prohibited acts
- [12]South Carolina Board of Medical Examiners: Notice Concerning the Prescribing of Research-Grade Peptides and FDA-Ineligible Peptides